Figure 4From: Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatmentForest plot depicting the meta-analysis for adverse events between IVR and non-anti-VEGF treatments. RR = risk ratio; CI = confidence interval.Back to article page